A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression
Clinical trial NCT07686445 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686445
- Sponsor
- Adlai Nortye Biopharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-23
- Primary completion
- 2028-12-31
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.